Using corticosteroids for severe COVID-19 treatment
Administration of Systemic Corticosteroids Among Critically Ill Patients With COVID-19: Electronic Survey (ASAP-C Study)
Brno University Hospital · NCT04648410
This study is trying to see how different doctors use corticosteroids to treat people with severe COVID-19 and what practices they follow.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 28 Days to 100 Years |
| Sex | All |
| Sponsor | Brno University Hospital (other) |
| Locations | 1 site (Brno) |
| Trial ID | NCT04648410 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the administration of systemic corticosteroids in patients with severe COVID-19, particularly focusing on the variations in clinical practice among intensive care professionals. It aims to gather insights through an electronic questionnaire sent to members of the European Society of Intensive Care, assessing their routine practices regarding corticosteroid use. The study addresses ongoing debates about the optimal dosage, timing, and type of corticosteroids for treating severe acute respiratory distress syndrome caused by COVID-19.
Who should consider this trial
Good fit: Ideal candidates for this study are members of the European Society of Intensive Care who treat patients with severe COVID-19.
Not a fit: Patients who are not members of the European Society of Intensive Care will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help standardize corticosteroid treatment protocols for severe COVID-19, potentially improving patient outcomes.
How similar studies have performed: Other studies, such as the RECOVERY trial, have shown success in using corticosteroids for severe COVID-19, indicating that this approach is supported by emerging evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Members of European Society of Intensive Care Exclusion Criteria: * not members of European Society of Intensive Care
Where this trial is running
Brno
- University Hospital Brno — Brno, Czechia (RECRUITING)
Study contacts
- Principal investigator: Jan Malaska, MD., Ph.D — University Hospital Brno
- Study coordinator: Jan Malaska, MD., Ph.D
- Email: jan.malaska@gmail.com
- Phone: 532232009
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Severe COVID-19